10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2021 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 15, 2022) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Revenues: | |||
| Premiums | $ 226,233 | 201,478 | 189,699 |
| Investment and other income | 2,324 | 1,502 | 1,886 |
| Total revenues | 287,597 | 257,141 | 242,155 |
| Operating costs: | |||
| Medical costs | 186,911 | 159,396 | 156,440 |
| Operating costs | 42,579 | 41,704 | 35,193 |
| Cost of products sold | 31,034 | 30,745 | 28,117 |
| Depreciation and amortization | 3,103 | 2,891 | 2,720 |
| Total operating costs | 263,627 | 234,736 | 222,470 |
| Earnings from operations | 23,970 | 22,405 | 19,685 |
| Interest expense | (1,660) | (1,663) | (1,704) |
| Earnings before income taxes | 22,310 | 20,742 | 17,981 |
| Provision for income taxes | (4,578) | (4,973) | (3,742) |
| Net earnings | 17,732 | 15,769 | 14,239 |
| Earnings attributable to noncontrolling interests | (447) | (366) | (400) |
| Net earnings attributable to UnitedHealth Group common shareholders | 17,285 | 15,403 | 13,839 |
| Earnings per share attributable to UnitedHealth Group common shareholders: | |||
| Basic | 18.33 | 16.23 | 14.55 |
| Diluted | 18.08 | 16.03 | 14.33 |
| Basic weighted-average number of common shares outstanding | 943 | 949 | 951 |
| Dilutive effect of common share equivalents | 13 | 12 | 15 |
| Diluted weighted-average number of common shares outstanding | 956 | 961 | 966 |
| Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 1 | 8 | 10 |
| Product and Service | |||
| Products | |||
| Revenue from Products and Services | 34,437 | 34,145 | 31,597 |
| Services | |||
| Revenue from Products and Services | 24,603 | 20,016 | 18,973 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2021 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 15, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Net earnings | $ 17,732 | 15,769 | 14,239 |
| Other comprehensive (loss) income: | |||
| Gross unrealized (losses) gains on investment securities during the period | (1,028) | 1,058 | 1,212 |
| Income tax effect | 248 | (253) | (279) |
| Total unrealized (losses) gains, net of tax | (780) | 805 | 933 |
| Gross reclassification adjustment for net realized gains included in net earnings | (173) | (75) | (104) |
| Income tax effect | 40 | 17 | 24 |
| Total reclassification adjustment, net of tax | (133) | (58) | (80) |
| Total foreign currency translation losses | (657) | (983) | (271) |
| Other comprehensive (loss) income | (1,570) | (236) | 582 |
| Comprehensive income | 16,162 | 15,533 | 14,821 |
| Comprehensive income attributable to noncontrolling interests | (447) | (366) | (400) |
| Comprehensive income attributable to UnitedHealth Group common shareholders | 15,715 | 15,167 | 14,421 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2021 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 15, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Operating activities | |||
| Net earnings | $ 17,732 | 15,769 | 14,239 |
| Noncash items: | |||
| Depreciation and amortization | 3,103 | 2,891 | 2,720 |
| Deferred income taxes | 130 | (8) | 230 |
| Share-based compensation | 800 | 679 | 697 |
| Other, net | (944) | (52) | (106) |
| Net change in other operating items, net of effects from acquisitions and changes in AARP balances: | |||
| Accounts receivable | (1,000) | (688) | 162 |
| Other assets | (1,031) | (2,195) | (1,563) |
| Medical costs payable | 2,701 | 152 | 1,221 |
| Accounts payable and other liabilities | 1,162 | 5,348 | 733 |
| Unearned revenues | (310) | 278 | 130 |
| Cash flows from operating activities | 22,343 | 22,174 | 18,463 |
| Investing activities | |||
| Purchases of investments | (17,139) | (16,577) | (18,131) |
| Sales of investments | 7,045 | 6,489 | 8,536 |
| Maturities of investments | 8,251 | 7,252 | 7,091 |
| Cash paid for acquisitions, net of cash assumed | (4,821) | (7,139) | (8,343) |
| Purchases of property, equipment and capitalized software | (2,454) | (2,051) | (2,071) |
| Other, net | (1,254) | (506) | 219 |
| Cash flows used for investing activities | (10,372) | (12,532) | (12,699) |
| Financing activities | |||
| Common share repurchases | (5,000) | (4,250) | (5,500) |
| Cash dividends paid | (5,280) | (4,584) | (3,932) |
| Proceeds from common stock issuances | 1,355 | 1,440 | 1,037 |
| Repayments of long-term debt | (3,150) | (3,150) | (1,750) |
| (Repayments of) proceeds from short-term borrowings, net | (1,302) | 872 | 300 |
| Proceeds from issuance of long-term debt | 6,933 | 4,864 | 5,444 |
| Customer funds administered | 622 | 1,677 | 13 |
| Purchases of redeemable noncontrolling interest | (1,338) | 0 | (618) |
| Other, net | (295) | (459) | (619) |
| Cash flows used for financing activities | (7,455) | (3,590) | (5,625) |
| Effect of exchange rate changes on cash and cash equivalents | (62) | (116) | (20) |
| Increase in cash and cash equivalents | 4,454 | 5,936 | 119 |
| Cash and cash equivalents, beginning of period | 16,921 | 10,985 | |
| Cash and cash equivalents, end of period | 21,375 | 16,921 | 10,985 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | 1,653 | 1,704 | 1,627 |
| Cash paid for income taxes | 3,966 | 4,935 | 3,542 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
UNITEDHEALTH GROUP INC | ||
Ticker: UNH Fiscal Year: 2021 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2021 10-K (Filed: Feb 15, 2022) | ||
| (In Millions) | ||
| As of | As of | |
| Dec 31, 2021 | Dec 31, 2020 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 21,375 | 16,921 |
| Short-term investments | 2,532 | 2,860 |
| Accounts receivable, net of allowances of $954 and $990 | 14,216 | 12,870 |
| Other current receivables, net of allowances of $993 and $1,047 | 13,866 | 12,534 |
| Assets under management | 4,449 | 4,076 |
| Prepaid expenses and other current assets | 5,320 | 4,457 |
| Total current assets | 61,758 | 53,718 |
| Long-term investments | 43,114 | 41,242 |
| Property, equipment and capitalized software, net of accumulated depreciation and amortization of $5,992 and $5,230 | 8,969 | 8,626 |
| Goodwill | 75,795 | 71,337 |
| Other intangible assets, net of accumulated amortization of $5,636 and $5,455 | 10,044 | 10,856 |
| Other assets | 12,526 | 11,510 |
| Total assets | 212,206 | 197,289 |
| Liabilities, redeemable noncontrolling interests and equity | ||
| Current liabilities: | ||
| Medical costs payable | 24,483 | 21,872 |
| Accounts payable and accrued liabilities | 24,643 | 22,495 |
| Short-term borrowings and current maturities of long-term debt | 3,620 | 4,819 |
| Unearned revenues | 2,571 | 2,842 |
| Other current liabilities | 22,975 | 20,392 |
| Total current liabilities | 78,292 | 72,420 |
| Long-term debt, less current maturities | 42,383 | 38,648 |
| Deferred Income Taxes | 3,265 | 3,367 |
| Other liabilities | 11,787 | 12,315 |
| Total liabilities | 135,727 | 126,750 |
| Commitments and contingencies (Note 12) | ||
| Redeemable noncontrolling interests | 1,434 | 2,211 |
| Equity: | ||
| Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding | 0 | 0 |
| Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding | 10 | 10 |
| Additional paid-in capital | 0 | 0 |
| Retained earnings | 77,134 | 69,295 |
| Accumulated other comprehensive loss | (5,384) | (3,814) |
| Nonredeemable noncontrolling interests | 3,285 | 2,837 |
| Total equity | 75,045 | 68,328 |
| Total liabilities, redeemable noncontrolling interests and equity | 212,206 | 197,289 |
| Preferred stock, par value | 0.00 | 0.00 |
| Preferred stock, shares authorized | 10 | 10 |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| Common stock, par value | 0.01 | 0.01 |
| Common stock, shares authorized | 3,000 | 3,000 |
| Common stock, shares issued | 941 | 946 |
| Common Stock, Shares, Outstanding | 941 | 946 |
| External Links | |
| UNITEDHEALTH GROUP INC (UNH) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |